COVID-19 Impact on Global IVD Infectious Diseases Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by IVD Infectious Diseases Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global IVD Infectious Diseases Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Immunochemistry
  • 1.4.3 Molecular Diagnostics
• 1.5 Market by Application
  • 1.5.1 Global IVD Infectious Diseases Market Share by Application: 2020 VS 2026
  • 1.5.2 Clinical Laboratories
  • 1.5.3 Diagnostic Centers
• 1.6 Coronavirus Disease 2019 (Covid-19): IVD Infectious Diseases Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the IVD Infectious Diseases Industry
    • 1.6.1.1 IVD Infectious Diseases Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and IVD Infectious Diseases Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for IVD Infectious Diseases Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 IVD Infectious Diseases Market Perspective (2015-2026)
• 2.2 IVD Infectious Diseases Growth Trends by Regions
  • 2.2.1 IVD Infectious Diseases Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 IVD Infectious Diseases Historic Market Share by Regions (2015-2020)
  • 2.2.3 IVD Infectious Diseases Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 IVD Infectious Diseases Market Growth Strategy
  • 2.3.6 Primary Interviews with Key IVD Infectious Diseases Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top IVD Infectious Diseases Players by Market Size
  • 3.1.1 Global Top IVD Infectious Diseases Players by Revenue (2015-2020)
  • 3.1.2 Global IVD Infectious Diseases Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global IVD Infectious Diseases Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global IVD Infectious Diseases Market Concentration Ratio
  • 3.2.1 Global IVD Infectious Diseases Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by IVD Infectious Diseases Revenue in 2019
• 3.3 IVD Infectious Diseases Key Players Head office and Area Served
• 3.4 Key Players IVD Infectious Diseases Product Solution and Service
• 3.5 Date of Enter into IVD Infectious Diseases Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global IVD Infectious Diseases Historic Market Size by Type (2015-2020)
• 4.2 Global IVD Infectious Diseases Forecasted Market Size by Type (2021-2026)

5 IVD Infectious Diseases Breakdown Data by Application (2015-2026)

• 5.1 Global IVD Infectious Diseases Market Size by Application (2015-2020)
• 5.2 Global IVD Infectious Diseases Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America IVD Infectious Diseases Market Size (2015-2020)
• 6.2 IVD Infectious Diseases Key Players in North America (2019-2020)
• 6.3 North America IVD Infectious Diseases Market Size by Type (2015-2020)
• 6.4 North America IVD Infectious Diseases Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe IVD Infectious Diseases Market Size (2015-2020)
• 7.2 IVD Infectious Diseases Key Players in Europe (2019-2020)
• 7.3 Europe IVD Infectious Diseases Market Size by Type (2015-2020)
• 7.4 Europe IVD Infectious Diseases Market Size by Application (2015-2020)

8 China

• 8.1 China IVD Infectious Diseases Market Size (2015-2020)
• 8.2 IVD Infectious Diseases Key Players in China (2019-2020)
• 8.3 China IVD Infectious Diseases Market Size by Type (2015-2020)
• 8.4 China IVD Infectious Diseases Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan IVD Infectious Diseases Market Size (2015-2020)
• 9.2 IVD Infectious Diseases Key Players in Japan (2019-2020)
• 9.3 Japan IVD Infectious Diseases Market Size by Type (2015-2020)
• 9.4 Japan IVD Infectious Diseases Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia IVD Infectious Diseases Market Size (2015-2020)
• 10.2 IVD Infectious Diseases Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia IVD Infectious Diseases Market Size by Type (2015-2020)
• 10.4 Southeast Asia IVD Infectious Diseases Market Size by Application (2015-2020)

11 India

• 11.1 India IVD Infectious Diseases Market Size (2015-2020)
• 11.2 IVD Infectious Diseases Key Players in India (2019-2020)
• 11.3 India IVD Infectious Diseases Market Size by Type (2015-2020)
• 11.4 India IVD Infectious Diseases Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America IVD Infectious Diseases Market Size (2015-2020)
• 12.2 IVD Infectious Diseases Key Players in Central & South America (2019-2020)
• 12.3 Central & South America IVD Infectious Diseases Market Size by Type (2015-2020)
• 12.4 Central & South America IVD Infectious Diseases Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 BD
  • 13.1.1 BD Company Details
  • 13.1.2 BD Business Overview and Its Total Revenue
  • 13.1.3 BD IVD Infectious Diseases Introduction
  • 13.1.4 BD Revenue in IVD Infectious Diseases Business (2015-2020))
  • 13.1.5 BD Recent Development
• 13.2 BioMerieux
  • 13.2.1 BioMerieux Company Details
  • 13.2.2 BioMerieux Business Overview and Its Total Revenue
  • 13.2.3 BioMerieux IVD Infectious Diseases Introduction
  • 13.2.4 BioMerieux Revenue in IVD Infectious Diseases Business (2015-2020)
  • 13.2.5 BioMerieux Recent Development
• 13.3 Abbott
  • 13.3.1 Abbott Company Details
  • 13.3.2 Abbott Business Overview and Its Total Revenue
  • 13.3.3 Abbott IVD Infectious Diseases Introduction
  • 13.3.4 Abbott Revenue in IVD Infectious Diseases Business (2015-2020)
  • 13.3.5 Abbott Recent Development
• 13.4 Quidel
  • 13.4.1 Quidel Company Details
  • 13.4.2 Quidel Business Overview and Its Total Revenue
  • 13.4.3 Quidel IVD Infectious Diseases Introduction
  • 13.4.4 Quidel Revenue in IVD Infectious Diseases Business (2015-2020)
  • 13.4.5 Quidel Recent Development
• 13.5 Gen-Probe
  • 13.5.1 Gen-Probe Company Details
  • 13.5.2 Gen-Probe Business Overview and Its Total Revenue
  • 13.5.3 Gen-Probe IVD Infectious Diseases Introduction
  • 13.5.4 Gen-Probe Revenue in IVD Infectious Diseases Business (2015-2020)
  • 13.5.5 Gen-Probe Recent Development
• 13.6 Abbott
  • 13.6.1 Abbott Company Details
  • 13.6.2 Abbott Business Overview and Its Total Revenue
  • 13.6.3 Abbott IVD Infectious Diseases Introduction
  • 13.6.4 Abbott Revenue in IVD Infectious Diseases Business (2015-2020)
  • 13.6.5 Abbott Recent Development
• 13.7 Danaher
  • 13.7.1 Danaher Company Details
  • 13.7.2 Danaher Business Overview and Its Total Revenue
  • 13.7.3 Danaher IVD Infectious Diseases Introduction
  • 13.7.4 Danaher Revenue in IVD Infectious Diseases Business (2015-2020)
  • 13.7.5 Danaher Recent Development
• 13.8 Sysmex
  • 13.8.1 Sysmex Company Details
  • 13.8.2 Sysmex Business Overview and Its Total Revenue
  • 13.8.3 Sysmex IVD Infectious Diseases Introduction
  • 13.8.4 Sysmex Revenue in IVD Infectious Diseases Business (2015-2020)
  • 13.8.5 Sysmex Recent Development
• 13.9 Orasure
  • 13.9.1 Orasure Company Details
  • 13.9.2 Orasure Business Overview and Its Total Revenue
  • 13.9.3 Orasure IVD Infectious Diseases Introduction
  • 13.9.4 Orasure Revenue in IVD Infectious Diseases Business (2015-2020)
  • 13.9.5 Orasure Recent Development
• 13.10 Hologic
  • 13.10.1 Hologic Company Details
  • 13.10.2 Hologic Business Overview and Its Total Revenue
  • 13.10.3 Hologic IVD Infectious Diseases Introduction
  • 13.10.4 Hologic Revenue in IVD Infectious Diseases Business (2015-2020)
  • 13.10.5 Hologic Recent Development
• 13.11 Cepheid
  • 10.11.1 Cepheid Company Details
  • 10.11.2 Cepheid Business Overview and Its Total Revenue
  • 10.11.3 Cepheid IVD Infectious Diseases Introduction
  • 10.11.4 Cepheid Revenue in IVD Infectious Diseases Business (2015-2020)
  • 10.11.5 Cepheid Recent Development
• 13.12 Qiagen
  • 10.12.1 Qiagen Company Details
  • 10.12.2 Qiagen Business Overview and Its Total Revenue
  • 10.12.3 Qiagen IVD Infectious Diseases Introduction
  • 10.12.4 Qiagen Revenue in IVD Infectious Diseases Business (2015-2020)
  • 10.12.5 Qiagen Recent Development
• 13.13 Roche Diagnostics
  • 10.13.1 Roche Diagnostics Company Details
  • 10.13.2 Roche Diagnostics Business Overview and Its Total Revenue
  • 10.13.3 Roche Diagnostics IVD Infectious Diseases Introduction
  • 10.13.4 Roche Diagnostics Revenue in IVD Infectious Diseases Business (2015-2020)
  • 10.13.5 Roche Diagnostics Recent Development
• 13.14 Siemens Healthcare
  • 10.14.1 Siemens Healthcare Company Details
  • 10.14.2 Siemens Healthcare Business Overview and Its Total Revenue
  • 10.14.3 Siemens Healthcare IVD Infectious Diseases Introduction
  • 10.14.4 Siemens Healthcare Revenue in IVD Infectious Diseases Business (2015-2020)
  • 10.14.5 Siemens Healthcare Recent Development
• 13.15 Bio-Rad Laboratories
  • 10.15.1 Bio-Rad Laboratories Company Details
  • 10.15.2 Bio-Rad Laboratories Business Overview and Its Total Revenue
  • 10.15.3 Bio-Rad Laboratories IVD Infectious Diseases Introduction
  • 10.15.4 Bio-Rad Laboratories Revenue in IVD Infectious Diseases Business (2015-2020)
  • 10.15.5 Bio-Rad Laboratories Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer